Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alector Inc 131 OYSTER POINT BLVD. SUITE 600 SOUTH SAN FRANCISCO CA 94080 USA

www.alector.com P: 415-231-5660

Description:

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 487,362
Enterprise Value, $K 412,802
Shares Outstanding, K 95,749
Annual Sales, $ 97,060 K
Annual Net Income, $ -130,390 K
Last Quarter Sales, $ 15,190 K
Last Quarter Net Income, $ -41,430 K
EBIT, $ -151,740 K
EBITDA, $ -158,210 K
60-Month Beta 0.79
% of Insider Shareholders 14.00%
% of Institutional Shareholders 85.83%
Float, K 82,344
% Float 86.00%
Short Volume Ratio 0.65

Growth:

1-Year Return -22.17%
3-Year Return -72.87%
5-Year Return -76.17%
5-Year Revenue Growth 250.65%
5-Year Earnings Growth 66.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 02/27/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -1.55
EPS Growth vs. Prev Qtr 7.55%
EPS Growth vs. Prev Year 22.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALEC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -77.15%
Return-on-Assets % -18.96%
Profit Margin % -134.34%
Debt/Equity 0.00
Price/Sales 5.00
Price/Cash Flow N/A
Price/Book 3.76
Book Value/Share 1.41
Interest Coverage -1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar